Pfizer is one of Ireland's leading employers and the largest pharmaceutical sector investor and employer. One of the first pharmaceutical companies to locate in Ireland (1969), Pfizer has a rich heritage of innovation and expansion over a forty year period. Pfizer has over 3,300 colleagues across 7 locations based in Cork, Dublin, Kildare and Sligo. Total capital investment by the company in Ireland exceeds $7billion.
Pfizer's business interests in Ireland are diverse which include manufacturing, shared services, R&D, treasury and commercial operations.
Ireland is a leading manufacturing base for Pfizer globally, exporting to global markets. There is a manufacturing presence in Active Pharmaceutical Ingredients, Solid Dose Pharmaceuticals, Sterile Injectables, Vaccines and Biopharmaceuticals. Many of Pfizer's leading and newest medicines are manufactured for global export from Irish sites. Part of Pfizer's Worldwide Research & Development (WR&D) is based in Ireland - the Global Biotherapeutics Technology group at Grange Castle was established in 2006 and is part of a world-leading protein drug discovery unit within Pfizer Worldwide R&D.
This report outlines Pfizer's presence in Ireland and highlights our efforts to contribute to the overall health, growth and wellness of this country. We are continually reviewing and improving our efforts to lessen Pfizer's impact on the environment, nurture a workplace of diversity and inclusion, conduct responsible business practices, and uphold the highest ethical standards in everything we do from research and development to sales and marketing.